Solid Biosciences Inc. is a life science company. The Company is focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Its lead program, SGT-001, is a gene transfer candidate under investigation for its... Read more
CNBC
CNBC
MarketWatch
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.